SCHEMBL12896902

SCHEMBL12896902

COc1ccc(F)cc1C1CCN(CC2CCOCC2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 6/20 0.57
CDK9 P50750 6/20 0.57
CCR5 P51681 2/20 0.48
OPRM1 P35372 1/20 0.45
OPRK1 P41145 1/20 0.45
OPRL1 P41146 1/20 0.45
DRD2 P14416 2/20 0.44
SLC6A3 Q01959 2/20 0.44
CHRM4 P08173 2/20 0.44
CHRM1 P11229 2/20 0.44
GRM2 Q14416 1/20 0.44
HTR2A P28223 2/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
HTR7 P34969 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM5 P08912 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12896769 0.86 MEN1 (0.50) CCNT1CDK9OPRM1OPRK1OPRL1
SCHEMBL12897167 0.85 DRD2 (0.61) OPRM1DRD2GRM2HTR7MEN1
SCHEMBL18361621 0.83 SLC6A2 (0.51) CDK9SLC6A3CHRM4CHRM1HTR2A
SCHEMBL12897021 0.81 CHRM4 (0.56) CCNT1CDK9DRD2SLC6A3CHRM4
SCHEMBL12896523 0.79 CHRM4 (0.63) CCR5CHRM4CHRM1HTR7CHRM2
SCHEMBL12897186 0.78 CCNT1 (0.48) CCNT1CDK9CCR5OPRM1OPRK1
SCHEMBL12897596 0.78 DRD2 (0.59) OPRM1DRD2GRM2HTR7MEN1
SCHEMBL12897160 0.77 CCNT1 (0.47) CCNT1CDK9CCR5OPRM1OPRK1
SCHEMBL12896860 0.77 CCNT1 (0.47) CCNT1CDK9CCR5OPRM1OPRK1
SCHEMBL12896714 0.77 HTR2A (0.43) CCR5DRD2SLC6A3GRM2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880007-B2 such as 1-bicyclo[2.2.1]hept-2-yl-4-(4-methoxy-2-methyl-phenyl)-piperidine, used for the treatment of chronic obstructive pulmonary disease, asthma, urinary incontinence, vision defects and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-01 US disclosed
US-7880007-B2 such as 1-bicyclo[2.2.1]hept-2-yl-4-(4-methoxy-2-methyl-phenyl)-piperidine, used for the treatment of chronic obstructive pulmonary disease, asthma, urinary incontinence, vision defects and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-01 US disclosed